Roche CEO Warns Against 'Middle Ground' Approach To Combat Pricing Pressure
This article was originally published in Scrip
Roche Holding AG's CEO Severin Schwan says the only surefire way to beat pricing pressures is to focus on "highly innovative medicines, differentiated medicines, medicines which provide significant value for patients". By doing this Roche has been "less exposed to price pressure not only in the US, but worldwide, and we see that in the numbers." The company reported third quarter sales on Oct. 22 that beat expectations.
Register for our free email digests: